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Abstract  
Introduction: Malignant transformation of endometriotic foci is a rare event occurring in 0.7-1% of patients with 
endometriosis. Of neoplasms that develop, endometrial stromal sarcoma (ESS) has been described and represent an 
extremely rare histological subtype [1].  Since its first description in the 1920s, only a handful of case reports have been 
published. The gastrointestinal tract is the most  common site for endometriosis associated ESS, although cases of ESS 
involving the mesentery, omentum, ovary, vagina, cervix, rectovaginal septum, parametrium, fallopian tube, pelvis, 
retroperitoneum, liver, and sciatic nerve have been reported [2-15]. 
Case Presentation: We present a case of diffuse metastatic high grade ESS as well as clear cell carcinoma of the ovary 
associated with endometriosis in a 45-year-old woman treated with complete cytoreductive surgery. 
Conclusion: The development of multiple malignancies arising from disseminated endometriotic foci in the abdominal 
cavity represents an extremely rare event. A high index of clinical suspicion is required to reach a diagnosis. 
Furthermore, no gold standard management option exists and treatment should be individualized.  
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Introduction 
Endometriosis represents extrauterine endometrial deposits of endometrial glands and stroma. When 
neoplasms arise from these endometriotic foci, carcinomas, sarcomas and mixed mullerian tumors have 
been reported histologies [16]. The criteria for diagnosis of a malignancy arising in endometriosis are (1) 
demonstration of a clear endometriotic area in the proximity of the tumor, (2) no other primary site for the 
tumor, and (3) histologic appearance consistent with an origin from endometriosis [17]. Since its first 
description by Sampson in the 1920s, only a handful of case reports have been published. The 
pathogenesis of extrauterine ESS is controversial. Some authors hypothesized that extrauterine ESS arise 
from a malignant transformation of endometriosis while others raised the possibility that they developed 
de-novo from mesothelial pluripotent mullerian cells [1,18].  
Case report  
Madam XY was a 45-year-old, Gravida 5, Para 5, pre-menopausal Malay lady, who presented 
with a one week history of progressive abdominal distention and bilateral lower limb swelling. She had 
no history of endometriosis, nor any menstrual- related complaints.  On examination, Madam XY 
appeared well, with no constitutional symptoms. Abdominal examination revealed a large abdominal 
mass arising from the pelvis and extending to the umbilical region. The mass was non tender. Moderate 
ascites was present and there was bilateral lower limb pitting edema. Biochemical investigations 
performed revealed an elevated Cancer Antigen (CA)-125 of 329IU/ml (normal < 35IU/ml), as well as 
severe anemia with a haemoglobin level of 5.7g/dl (normal range 12-16g/dl). PV and PR examination did 
not reveal any abnormalities.  Subsequently, a contrasted computer tomography (CT) scan showed a 25 
x 25 x 19 cm heterogenous solid cystic mass extending from the left adnexa to the mid abdomen. The 
mass was adherent to the sigmoid and descending colon and appeared inseparable from multiple small 
bowel loops with significant mural involvement. There were no suspicious lesions in the liver (Figure 1 
and 2). An oesophagogastroduodenoscopy (OGD) showed antral gastritis, as well as, a benign antral ulcer. 
Colonoscopy revealed no luminal or submucosal masses. However, there was extrinsic compression from 
an extraluminal mass that prevented complete evaluation of the large colon proximal to the hepatic 
flexure. The initial differential diagnoses were either that of a left ovarian carcinoma, or a Gastrointestinal 
stromal tumour (GIST) arising from the small bowel. A staging CT Thorax scan revealed no pulmonary 
metastasis.  
The case was discussed at a multi-disciplinary tumour board, and the decision was made for complete 
cytoreductive surgery, in the absence of distant metastasis. 
Madam XY was optimized for surgery, and her Hb was topped up to 8.9g/dl. She underwent a 
laparotomy, and intra- operative findings included a large intra- abdominal tumor with haemoperitoneum 
arising from the mid jejunum. The mass was adherent to the sigmoid, descending colon, uterus and left 
ovary. In addition, multiple small tumor nodules was found scattered on the surrounding small bowel 
mesentery, limited to a 29 cm section of the small bowel. Frozen section diagnosis was that of a poorly 
differentiated tumour, and scattered spindle cells were also observed. She underwent an enbloc resection 
of the large tumor mass and small bowel mesenteric nodules that necessitated a high anterior resection, 
left salpingo-oophorectomy, omentectomy and small bowel resection. 
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Figure 1 Large intra-abdominal mass with mural involvement of multiple small 
bowel loops 
Figure 2 Left adnexal mass which appears inseparable the mass
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Histology of the small bowel, omental, descending colon tumor all returned with the diagnosis of high 
grade endometrial stromal sarcoma. Numerous scattered endometriotic foci was found adherent to the left 
ovary, fallopian tube, colon and small bowel. Replacement of endometrial like stromal cells by malignant 
stromal cells was appreciated. While tumor deposits found on the surface of the left ovary were ESS, a 
discrete, well-circumscribed 1.6cm nodule was found within the ovarian stroma. The latter had features 
consistent with clear cell carcinoma of the ovary.   
Microscopic sections of the tumor showed a range round to oval to spindle-shaped cells arranged in 
sheets (Figure 3). Within these sheets of tumor cells were multiple foci of benign looking strips and 
glands of epithelium. A high mitotic count (>20/10 HPF) was noted. On immunohistochemical staining, 
tumor cells showed diffuse immunoreactivity to CD10 and cyclin D1. They were negative for estrogen 
and progesterone receptors, cytokeratin, CD-117, S-100 protein, CD 34, smooth muscle actin (SMA), and 
beta-catenin.  
All resection margins were free of tumor cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Madam XT’s postoperative recovery was uneventful and she was discharged well on post operative 
day 5. Given the unusual situation of a dual malignancy, the choice of adjuvant therapy posed a challenge. 
While the optimal treatment of clear cell carcinoma of the ovary is taxane or platinum-based adjuvant 
chemotherapy, this was of questionable benefit in the management of ESS. Radiotherapy and hormonal 
therapy was offered for the management of high grade ESS but only in the context of a clinical trial. The 
patient however declined all adjuvant therapy. 
 
Figure 3 High powered view of High Grade ESS 
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Discussion 
Endometriosis is a relatively common gynecological condition and is known to be associated with 
infertility as well as gynecological complaints such as dysmenorrhoea, menorrhagia and dysparenuria. 
Even though a benign clinical course is often predicted, it is estimated that up to 1% of women with 
endometriosis will develop endometriosis-associated malignancy. ESS represents one of the rare 
histopathological subtypes of malignancy arising from endometriosis.  
In previously reported case reports, the age at diagnosis ranged from 31 to 75 years [4,18-21]. 
Presenting symptoms were varied but the most common complaint was that of vague abdominal pain, 
followed by per rectal bleeding and difficulty in defecation. The sigmoid colon and rectum are areas of 
the gastrointestinal tract with the highest incidence of endometriosis, and hence the most commonly 
reported sites of ESS.  In Mdm XY,  ESS arose mainly from the endometriotic foci deposited on small 
bowel, and as such she did not present with colorectal related symptoms. She also did not experience any 
per- vaginal bleeding. This posed a diagnostic challenge.  
ESS is a malignancy of the endometrial stromal cells of a normal proliferative endometrium. 
Microscopic features include: invasive ‘tongues’, short regular fasicles or sheets of monomorphous plump 
oval to spindle cells admixed with scattered prominent arterioles [3,14,22]. A possible differential 
diagnosis in the presence of spindle cells is gastrointestinal stromal tumor (GIST). Immunohistochemical 
staining is useful in differentiating these two entities. GISTs are strongly and diffusely for CD117 (c-KIT) 
while ESS often stains positive for vimentin, CD10, Estrogen(ER) and Progesterone receptors (PR). In 
our case, tumour cells stained positive for CD10 and cyclin D1; and were negative for ER, PR and c-KIT. 
The surrounding entrapped epithelium was positive for Cytokeratin 7(CK7), Epithelial Membrane 
Antigen (EMA), Beta-Catenin and negative for CK20. This was suggestive of cells of Mullerian origin.  
In Mdm XY, a dual pathology was present: disseminated high grade ESS and clear cell carcinoma of 
the left ovary. Endometriosis is present in up to 30% of women with ovarian cancer [23] ; when they 
co-exist, there are 2 possibilities: (1) malignant transformation of benign endometriosis into ovarian 
cancer, and (2) de-novo development of carcinoma with incidental findings of endometriosis [24,25]. In 
our patient, histological findings suggest that the clear cell ovarian carcinoma arose from endometriosis, 
as did the ESS. A case of 2 distinct malignancies developing from endometriotic foci has not been 
reported in literature. 
The cornerstone for treatment of ESS is complete cytoreductive surgery (CRS). In patients with low 
grade ESS, radical surgery has yielded good outcomes in most of the reported cases. Some authors 
propose that a combination of surgery and adjuvant radiotherapy resulted in the lowest recurrence rates 
while others report superior overall survival rates with the use of adjuvant hormonal therapy [19,26,27].  
Radiotherapy may provide local control in the setting of uterine ESS, however, the same may not be 
applied to extra-uterine foci of ESS developing from endometriosis. As such, no absolute treatment 
protocol has been established for the management of extra-uterine ESS. Furthermore, reported prognosis 
of high grade ESS is dismal even with the use of adjuvant therapies [28,29]. CRS and hyperthermic 
intraperitoneal chemotherapy (HIPEC) has been adopted as a modality of treatment for peritoneal 
dissemination from colon, ovarian and primary peritoneal malignancies [30-32]. Its use has also been 
reported in high grade uterine sarcomas with peritoneal dissemination [33]. In Mdm XY, ESS arising 
from endometriotic foci was found scattered throughout the abdominal cavity, and represent a form of 
‘peritoneal sarcomatosis’. In the absence of improved outcomes with traditional adjuvant therapy, 
CRS/HIPEC could be considered as an option in selected patients.  
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Conclusion  
Our case represents a highly rare event where there was development of multiple high-grade ESS from 
disseminated endometriotic foci in the abdominal cavity. A high index of clinical suspicion is required, 
especially in women with known histories of endometriosis for the early detection of malignant 
transformation of this supposedly benign gynecological condition. Due to the rarity of such tumors, no 
gold standard management option exists. This draws importance to the need for various specialist centers 
worldwide to share their experience so that further progress may be made to optimize therapeutic options 
for patients with this rare disease.  
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